None listed
Conditions
Interventions
Dietary Supplement : Consumption of GF bacillus antioxidant enzyme SOD or placebo, 2 times/day, 1 tablet at an one time during 8 weeks
Sponsors
Ewha Womans University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject who voluntarily agree to participate and signs informed consent form 2) Age more than 30 year old and less than 65 years old (Ratio of men and women 1:1) 3) Less than 36 of Recommended Foods Score 4) Subject who comply more than one thing of the following categories -150mg/dL =Blood triglycerides< 200 mg/dL -200mg/dL =Blood total cholesterol< 240 mg/dL -130mg/dL =Blood LDL-cholesterol< 160 mg/dL
Exclusion criteria
Exclusion criteria: 1) Impossible to performa treadmill activity 2) Continuous intensive workout (more than 7 hours a week) within 3 months from the first visit 3) Chronic smoker (= 10 cigarettes / day) 4) Intake more than 420 g of pure alcohol a week (Soju 7bottles/week, 1bottle/day) or an alcoholic 5) BMI<23 or BMI=30 6) Controlling body weight or have changed of body weight more than 4kg within 4 weeks before the first visit 7) Having difficult to consist the current workout habits or diet habits during the study 8) Comply the following categories - Treated with hormone treatment within 6 months before the first visit - Have following diseases or taking relevant medicines: thromboembolism, inflammatory disease, liver disease, kidney disease, cerebrovascular disease, cancer, uterine disease, Cardiovascular disease( hypertension, stroke etc), thyroid disease, interstinal disease, diabetes or hyperlipidemia with drug treatment - A mental patient - Therapeutic uses of coumadin, aspirin, or other medications that influence hemostasis within four weeks of the Screening visit. Preventive use of low-dose aspirin (e.g. 100-mg a day) is allowed. 9) Continuous consumption of health functional food(rasberry wine, Pycnogenol, Coenzyme Q10, meron extract, antioxidantsmultivitamin etc), prebiotics (dietary fiber, oligosaccharide etc) and probiotics (lactobacillus) within 1 months before the first visit 10) Donated blood within 1 month before the first visit 11) Known hypersensitivity to study product or any ingredient in study product 12) Planning to be pregnant, Pregnant or lactating women 13) Participation in other human study within 1 month before the first visit 14) Subject who has difficult to handle smartphone 15) Any condition that the principal investigator believes may put the subjects at under risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| antioxidant enzyme activity (Superoxide dismutase, glutathione peroxidase, catalase activity);glutathione | — |
Secondary
| Measure | Time frame |
|---|---|
| malondialdehyde | — |
Countries
Korea, Republic of
Contacts
Public ContactYunsoo Kim
Ewha Womans University
Outcome results
None listed